| Numéro de catalogue | HS856026 |
| Espèce hôte | Human |
| Reactivité des espèces | Human |
| Forme | Liquid |
| Tampon de stockage | 0.01M PBS, pH 7.4. |
| Pureté | >95% purity as determined by SDS-PAGE. |
| Clonalité | Monoclonal |
| Isotype | IgG1-kappa |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Cible | CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A |
| Purification | Protein A/G purified from cell culture supernatant. |
| Niveau d'endotoxines | Please contact the lab for this information. |
| Système d'expression | Mammalian Cells |
| Numéro d'accès | Q16552 |
| Stabilité et stockage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternative name | AIN457, 1229022-83-6 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Research Grade Secukinumab
Aperçu
Description
Secukinumab (HS856026) is a research-grade recombinant antibody targeting CTLA-8. Produced in mammalian cells with native-like glycosylation.
Highlights
- ●Research Grade — For PK/PD studies, assay development, and ADA research.
- ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Images
 SDS-PAGE |
SDS-PAGE for Research Grade Secukinumab. |
 SEC-HPLC |
SEC-HPLC detection for Research Grade Secukinumab. |
 Bioactivity |
Detects Human IL17A in indirect ELISAs. |